Clinical Trial Update: S-ICD® System Post Approval Study

View source ↗

Summary

Post-approval study update for the S-ICD System (Boston Scientific) completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Cardiac Arrest

Drugs mentioned

• S-ICD System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Primary Prevention of Sudden Cardiac Arrest, Secondary Prevention of Sudden Cardiac Arrest | Status: COMPLETED | Results posted: 2024-03-18